Executive at PROCEPT BioRobotics (PRCT) earns 4,872 performance-based shares

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp executive receives stock from performance award

EVP and Chief Legal Officer Nouri Alaleh acquired 4,872 shares of PROCEPT BioRobotics common stock through a grant at a price of $0.00 per share. After this award, Alaleh directly holds 77,345 common shares.

The shares represent common stock underlying a portion of previously granted performance stock units. The company’s Compensation Committee certified on February 19, 2026 that required performance goals were achieved, causing these units to be deemed earned. The earned shares are scheduled to vest on March 5, 2026, with each unit corresponding to one share of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nouri Alaleh

Role EVP, CLO, CORP. SEC.

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,872	$0.00	--

Holdings After Transaction: Common Stock — 77,345 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nouri Alaleh

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO, CORP. SEC.

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		A		4,872(1)	A	$0	77,345	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PROCEPT BioRobotics (PRCT) report for Nouri Alaleh?

PROCEPT BioRobotics reported that EVP and Chief Legal Officer Nouri Alaleh acquired 4,872 shares of common stock. The shares came from previously granted performance stock units that were deemed earned after performance goals were certified by the Compensation Committee.

How many PROCEPT BioRobotics shares does Nouri Alaleh hold after this Form 4 filing?

After this transaction, Nouri Alaleh directly holds 77,345 shares of PROCEPT BioRobotics common stock. This reflects the addition of 4,872 earned shares underlying performance stock units that were certified as achieved and scheduled to vest on March 5, 2026.

What triggered the vesting of Nouri Alaleh’s performance stock units at PROCEPT BioRobotics?

The vesting was triggered when PROCEPT BioRobotics’ Compensation Committee certified on February 19, 2026 that specified performance criteria were achieved. As a result, 4,872 performance stock units were deemed earned and are scheduled to vest on March 5, 2026 as common shares.

Did Nouri Alaleh pay a purchase price for the PROCEPT BioRobotics shares in this Form 4?

No cash purchase was involved; the 4,872 shares were acquired at a reported price of $0.00 per share. They represent common stock underlying previously granted performance stock units that became earned upon achievement of company performance criteria.

What type of equity award did PROCEPT BioRobotics use for Nouri Alaleh’s Form 4 transaction?

The transaction involved performance stock units, or PSUs. Each PSU represents a contingent right to receive one share of PROCEPT BioRobotics common stock, which becomes earned when predetermined performance goals are certified as achieved by the Compensation Committee.

When will the earned performance stock units for PROCEPT BioRobotics EVP Nouri Alaleh vest?

The earned performance stock units underlying 4,872 shares are scheduled to vest on March 5, 2026. They were deemed earned after the Compensation Committee certified achievement of the required performance criteria on February 19, 2026, with each unit delivering one share of common stock.